Product Theater: TREMFYA: A Selective IL-23 Inhibitor With Pivotal Studies vs. Adalimumab

Summary: This Product Theater, sponsored by Janssen Biotech, Inc., is from the SDPA Annual Summer Dermatology Conference 2018, held June 27 – July 1, 2018 in Seattle, Washington. Topic: TREMFYA: A Selective IL-23 Inhibitor With Pivotal Studies vs. Adalimumab Faculty: Cynthia Trickett, MPAS, PA-C, DFAAPA